Hyperliquid Strategies (NASDAQ:PURR) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

Hyperliquid Strategies (NASDAQ:PURR) had its target price upped by equities researchers at Cantor Fitzgerald from $22.60 to $34.20 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 184.29% from the stock’s current price.

Other research analysts have also issued reports about the company. Wall Street Zen lowered Hyperliquid Strategies from a “hold” rating to a “sell” rating in a research report on Saturday, August 29th. Weiss Ratings raised Hyperliquid Strategies from a “sell (d+)” rating to a “hold (c)” rating in a research note on Friday, August 28th. Finally, Chardan Capital lifted their price objective on Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a “buy” rating in a research note on Friday, August 28th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.40.

Hyperliquid Strategies Stock Performance

Shares of NASDAQ PURR opened at $12.03 on Thursday. The firm has a 50 day moving average price of $8.45 and a two-hundred day moving average price of $7.32. The stock has a market cap of $2.38 billion, a P/E ratio of -1.87 and a beta of 1.89. Hyperliquid Strategies has a 52-week low of $3.01 and a 52-week high of $14.14.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. State of Wyoming bought a new position in Hyperliquid Strategies during the second quarter worth $46,000. Shepherd Financial Partners LLC bought a new stake in Hyperliquid Strategies in the second quarter valued at $79,000. Boothbay Fund Management LLC acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at about $40,000. Lotus Technology Management LP acquired a new position in shares of Hyperliquid Strategies during the second quarter valued at about $93,000. Finally, XTX Topco Ltd bought a new position in shares of Hyperliquid Strategies during the 4th quarter worth about $48,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.